Filter
375
Filtered Results: 375
Text search:
JAMA
Network
Featured
Recommendations
42
New Publications
52
Language
Document type
No document type
148
Guidelines
104
Studies & Reports
83
Manuals
17
Training Material
7
Strategic & Response Plan
7
Situation Updates
4
Fact sheets
4
Resource Platforms
1
Countries / Regions
Global
16
India
15
Brazil
13
Russia
12
Africa
11
Latin America and the Carribbean
11
Western and Central Europe
10
Mozambique
7
Eastern Europe
7
Syria
6
Germany
6
Ukraine
5
East and Southern Africa
5
Eastern Europe and Central Asia
4
South Africa
4
Angola
4
Kenya
3
Rwanda
3
Nigeria
3
Philippines
3
West and Central Africa
3
Middle East and North Africa
3
Uganda
3
Liberia
3
Thailand
2
Sierra Leone
2
Guinea
2
Guinea-Bissau
2
Tanzania
2
South–East Asia Region
2
North America
2
Portugal
2
Tajikistan
1
Colombia
1
Mexico
1
Turkey
1
Ghana
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Zimbabwe
1
USA
1
Cambodia
1
Congo, Democratic Republic of
1
France
1
United Kingdom
1
Spain
1
Bangladesh
1
Vietnam
1
Yemen
1
Ethiopia
1
South Sudan
1
Indonesia
1
Iraq
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
89
Public Health
32
Clinical Guidelines
26
Women & Child Health
20
Pharmacy & Technologies
7
Key Resources
5
Capacity Building
1
Toolboxes
COVID-19
107
Mental Health
52
HIV
31
NCDs
27
TB
16
AMR
15
Planetary Health
11
Caregiver
7
Global Health Education
7
Rapid Response
6
Refugee
6
Ebola
6
Health Financing Toolbox
5
Conflict
4
Disability
3
Polio
3
Natural Hazards
2
Pharmacy
2
Specific Hazards
1
Cholera
1
NTDs
1
Zika
1
Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID...
The article outlines the prioritized research agenda for the prevention and control of chronic respiratory diseases (CRDs) as part of the World Health Organization's (WHO) action plan on noncommunicable diseases (NCDs) from 2008 to 2013. It highlights the significant global impact of CRDs, including...
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as the most common chronic disease in children, issues of underdiagnosis and undertreatment persist. There are substantial globa...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
